News from immunovaccine inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 08, 2012, 10:00 ET

Immunovaccine Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

 Immunovaccine Inc., (TSX-V: IMV), a clinical stage vaccine company, announced that their October 4th RetailInvestorConferences.com...

Oct 02, 2012, 12:39 ET

Immunovaccine Inc. to Webcast, Live, at RetailInvestorConferences.com on October 4th

Immunovaccine Inc., (TSX-V: IMV), a clinical stage vaccine company, announced that John Trizzino, chief executive officer and director, will...

Aug 05, 2009, 09:00 ET

ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery

HALIFAX, NS, Aug. 5 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, has signed an agreement with...

Jul 14, 2009, 09:00 ET

ImmunoVaccine Technologies Licenses Immunotope's Breast, Ovarian and Prostate Cancer Antigens

HALIFAX, NS, July 14 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, has entered into an agreement to...

May 26, 2009, 06:00 ET

ImmunoVaccine Technologies Partners with FIT Biotech to advance a therapeutic HIV vaccine

HALIFAX, NS, May 26 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, announced a research partnership...

May 20, 2009, 10:57 ET

ImmunoVaccine Technologies Collaborates with NRC Institute for Biodiagnostics Atlantic to measure effectiveness of DepoVax(TM) with novel MRI Imaging

HALIFAX, May 20 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, has announced a collaboration agreement with...

Apr 14, 2009, 09:00 ET

ImmunoVaccine Technologies Collaborates with Defence Research Development Canada to Strengthen Canada's Ability to Deal with Biological Threats

HALIFAX, April 14 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, has announced the signing of a 3-year...

Mar 27, 2009, 09:00 ET

ImmunoVaccine Technologies Signs Agreement with La Jolla Institute for Allergy & Immunology to Test the Application of DepoVax(TM) Technology to Battle Influenza

HALIFAX, March 27 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, has signed an agreement with the La Jolla...

Feb 25, 2009, 09:00 ET

ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria

HALIFAX, NS, Feb. 25 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, has signed a collaborative agreement with...

Jan 09, 2009, 10:00 ET

ImmunoVaccine Technologies Presents at OneMed Place Finance Forum

HALIFAX, NS, Jan. 9 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, announced today that it will present at...

May 23, 2008, 01:00 ET

ImmunoVaccine Technologies Congratulates Dr. Ramila Philip as One of PA's Best 50 Women in Business

HALIFAX, May 23 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, congratulates Dr. Ramila Philip for being...

Apr 30, 2008, 01:00 ET

ImmunoVaccine Technologies Patents DepoVax(TM) Vaccine Platform

HALIFAX, April 30 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, unveiled today its DepoVax(TM) platform, a...

Feb 20, 2008, 00:00 ET

ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair

HALIFAX, Feb. 20 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, announced today the appointment of former...

Jan 23, 2008, 00:00 ET

ImmunoVaccine Technologies Discusses Phase I Clinical Trial Application

HALIFAX, Jan. 23 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT) announced today that it has met with Health Canada's regulatory affairs...

Jan 21, 2008, 00:00 ET

ImmunoVaccine Technologies Receives $3 Million From ACOA

HALIFAX, Jan. 21 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a clinical stage vaccine development company, will receive $3 Million from...

Jan 14, 2008, 00:00 ET

ImmunoVaccine Technologies licenses the VacciMax(R) platform to Pfizer Animal Health for future animal vaccine applications

HALIFAX, Jan. 14 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), announced today that it had signed licensing agreements for Pfizer Animal...

Jan 07, 2008, 00:00 ET

ImmunoVaccine Technologies to Present at OneMed Place Finance Forum

HALIFAX, Jan. 7 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine enhancement company, announced today that it will present at the...

Dec 10, 2007, 00:00 ET

ImmunoVaccine Technologies Inc. to Acquire Immunotope Inc.

HALIFAX, Dec. 10 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a Nova Scotia-based vaccine enhancement company, has signed a binding...

Nov 29, 2007, 00:00 ET

ImmunoVaccine Technologies Inc. Completes Scale-Up of VacciMax(R) to Commercially Relevant Scale

HALIFAX, Nov. 29 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT) announced today that it has successfully scaled-up the manufacturing...

Sep 27, 2007, 01:00 ET

ImmunoVaccine Technologies Inc. Nears Phase I Clinical Trials with Completion of Scientific Advisory Board

HALIFAX, Sept. 27 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT) finalizes an important step in its progress with the last appointment to...